Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Annaly Capital

AT&T

Dividend stocks have historically run circles around companies that don't pay a dividend.

3 High-Yield Dividend Stocks That'll Make You Richer in 2021

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has administered more than 1 million COVID-19 vaccinations across long-term care facilities and other vulnerable populations identified as part of state and jurisdiction distribution plans. The company also remains on track to complete the administration of COVID-19 vaccine first doses in skilled nursing facilities by Monday, Jan. 25. Walgreens began administering COVID-19 vaccinations as part of the Centers for Disease Control and Prevention (CDC) Ph

Walgreens Completes More Than 1 Million COVID-19 Vaccinations

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will hold its virtual annual stockholders' meeting on Jan. 28, 2021 at 8:00 a.m. CST.

Walgreens Boots Alliance to Webcast Virtual Annual Meeting of Stockholders

The company recently announced it would be selling off the bulk of its wholesale business.

Does This Recent News Make Walgreens a Better Buy?

Amgen

Cisco Systems

Dow Inc

Coca-Cola

Merck

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

The Dogs of the Dow is a venerable strategy. But some dogs are better than others.

Dogs Of The Dow: Best And Worst Breeds

Kirkland Lake Gold

Teva Pharmaceutical

Things are looking up for these beaten-down value plays in the new year.

3 Turnaround Stocks That Will Make You Richer in 2021

Agilent Technologies

Baxter

Centene

Veeva Systems

According to the GuruFocus All-in-One Screener as of Jan. 15, the following Health Care stocks are popular among gurus.

5 Health Care Stocks Gurus Are Buying

BLOOMFIELD HILLS, Mich., Jan. 14, 2021 /PRNewswire/ -- OFP Real Estate, LLC (a/k/a One Family Property) ("OFP") announced today that it closed on the acquisition of a net-leased investment tenanted by Walgreens Boots Alliance (NASDAQ: WBA) located in a Cleveland, Ohio metro market. The...

One Family Property Announces Acquisition Of Investment Property

Synchrony Financial

As part of a larger financial services push from Walgreens, the drugstore will  team up with major private-label issuer Synchrony to debut a prepaid debit card, a store card, and a cobranded credit card set to run on the Mastercard network. Details remain scarce, but the cards, which are set to debut in H2 2021, will be tied to the chain's new myWalgreens loyalty program and offer cash rewards, among other perks. The cobrand will also feature benefits on health and wellness spending specifically.

Synchrony and Walgreens are teaming up to debut a card portfolio

Mastercard

The relationship announced Wednesday (Jan. 13) between Walgreens, Mastercard and Synchrony is more than a standard co-brand deal. The three companies will now team up to provide a mix of data, payment vehicles and loyalty program enhancements.

Mastercard's Saxena: Walgreens Deal Addresses Dual Priorities Of Payments And Healthcare

Walgreens Boots Alliance, Inc. (WBA) Management Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

Amid its continuing commitment to provide healthcare offerings and benefits to shoppers, Walgreens is growing its financial services offering with the help of Synchrony and Mastercard. In the months to come, the retailer will roll out Synchrony-issued credit cards in addition to a prepaid debit card that will be fueled by the Mastercard network, according […]

Walgreens To Roll Out Co-Branded Cards With Mastercard, Synchrony

Walgreens Boots Alliance Inc. said Wednesday that it will expand its partnerships with Synchrony Financial and Mastercard Inc. with credit cards and a prepaid debit card. The credit cards will be tied to the pharmacy retailer's newly-launched loyalty program, offering points as well as other benefits.

Walgreens to launch credit cards with Synchrony Financial and Mastercard

The drugstore chain is looking for growth opportunities as consumers shop more online and competitors take some of its business.

Walgreens looks to credit card, financial services to drive loyalty and boost revenue

AvalonBay Communities

If the new administration is successful in passing $2,000 stimulus payouts, these income stocks could line your pockets for a long time to come.

The Best High-Yield Dividend Stocks to Buy With a $2,000 Stimulus Check

DEERFIELD, Ill. & JOHNSON CITY, N.Y.--(BUSINESS WIRE)--Walgreens Boots Alliance and iA announced that WBA has made a majority investment in iA to advance automation capabilities for the pharmacy industry.

Walgreens Boots Alliance Makes a Majority Investment into iA to Advance Automation Capabilities for the Pharmacy Industry

First of Long Island

Telephone and Data Systems

Dividend Champions, or dividend aristocrats, are great dividend stocks because they've raised dividends for at least 25 consecutive years. The post 3 Dividend Champions for Yield and Total Returns appeared first on InvestorPlace.

3 Dividend Champions for Yield and Total Returns

Chevron

Microsoft

Tesla

Vanguard Energy ETF

Data indicates The Dogs of the Dow outperform over long time frames. I contend the Dogs provide a good risk/reward profile for Dividend Growth investors.

The Dogs Of The Dow: My Plan To Improve On The Market Beating Strategy

Shares of pharmacy retailer Walgreens Boots Alliance Inc (NASDAQ: WBA) ended 2020 lower by nearly 30%, but Baird sees several catalysts for the company that it said should put an end to years of "train wreck" performance. The Walgreens Analyst: Eric Coldwell upgraded Walgreens from Neutral to Outperform with a price target lifted from $41 to $55.

Baird Upgrades Walgreens Boots, Expects Turnaround Of 'Train Wreck' Performance

D.R. Horton

FedEx

General Motors

JPMorgan Chase & Co

Prudential Financial

Here are seven cheap stocks with solid businesses that may power portfolios in 2021 The post The 7 Best Cheap Stocks to Kick Off 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets

The 7 Best Cheap Stocks to Kick Off 2021

CVS Health

Rite Aid

The three drugstore chains have expanded their digital offerings and stepped up their focus on health and wellness to keep up with consumer preferences.

Covid vaccinations offer CVS, Walgreens and Rite Aid a chance to showcase how drugstores have changed

For income investors, dividend strategies don't come any easier than the “Dogs of the Dow.”

Dogs Of The Dow 2021: Buy, Hold Or Sell These 10 Dividends?

Yamana Gold

Exelixis

Wells Fargo

Bargains are plentiful for value investors in the new year.

5 Value Stocks That Will Make You Richer in 2021

COVID-19 didn't give Walgreens Boots Alliance the windfall you might think in 2020.

Why Shares of Walgreens Boots Alliance Dropped 29.4% in 2020

Advanced Micro Devices

Dollar General

Procter & Gamble

Simply Good Foods

Constellation Brands

T-Mobile US

As 2021 starts, long-term investments may look a little shaky, which could make now an ideal time to look for short-term stocks to buy. The post 7 Short-Term Stocks to Move Quickly On appeared first on InvestorPlace.

News for Walgreens Stock (WBA)